Individualized risk assessment, patient education, and careful dose titration are essential for optimizing long-term tolerability
ABSTRACT Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as game-changers across the cardiovascularkidneymetabolic (CKM) spectrum: overweight/obesity, type 2 diabetes mellitus (T2DM) and associated chronic kidney disease (CKD) and cardiovascular disease (CVD)
Mistake 2: skipping titration steps Impatient researchers sometimes jump from 2mg directly to 8mg, or from 4mg straight to 12mg, reasoning that they tolerated the lower dose well and want faster results
Support healthy weight management with a simple-to-take oral spray taken twice daily
Stanley, B
"Our position is that more supply, especially at a reasonable price, is needed right now, not less," Noom CEO Geoff Cook told CNBC in an interview